The point of parallel imports of pharmaceuticals is arbitrage between countries with different prices. For several years, an important issue in the European Union (EU) has been the evident conflict between differing price regulations in the member states, on the one hand, and the consequences of parallel trade, on the other. In the EU, so long as the manufacturer has placed the good on the market voluntarily, the principle of free movement of goods...
Подробнее
ПОДРОБНАЯ ИНФОРМАЦИЯ
-
2001/07/31
-
Рабочий документ в рамках исследования вопросов политики
-
WPS2630
-
1
-
1
-
2010/07/01
-
Parallel imports of pharmaceutical products in the European Union
-
protection of intellectual property right